Yoshiya Yamada, MD, Radiation Oncologist at Memorial Sloan Kettering Cancer Center in New York City discusses radiosurgery (SRS) versus conventional fractionated radiotherapy for spinal and bone metastases. He begins by discussing histologic classification in terms of radiosensitivity and radioresistance and how that applies to spinal metastases before giving an overview of the results of several related studies.
Niko Papanikolaou, PhD, from UT Health San Antonio MD Anderson Cancer Center shares his institution’s experiences with commissioning and clinical implementation of Brainlab Elements Spine SRS software. He begins by giving an overview of the software itself, including spinal curvature correction, spine contouring, VMAT optimization, user defined protocol based planning and Monte Carlo based dose calculation. He then shares a treatment planning study to evaluate the clinical benefit of Spine SRS compared to Pinnacle and Monaco treatment planning systems. Finally, Dr. Papanikolaou discusses commissioning including the phantoms used.